Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCT8D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,696
Award facts
- Contract value 100% obligated
- $16,696.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,696.23 for Dupixent 300 mg/2 ml pen injectors on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded to the company's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters, where pharmaceutical distribution and supply chain operations are coordinated.
This delivery order falls under AmerisourceBergen's larger $999.999 billion IDC with DLA Troop Support Medical (designated SPE2DX), extending through December 2026, which serves as a comprehensive pharmaceutical prime vendor vehicle supporting military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award of this specific delivery order for Dupixent, a specialty pharmaceutical used in treating conditions such as atopic dermatitis and eosinophilic disorders, demonstrates the company's role in supplying both brand-name specialty medications and essential healthcare commodities to support military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCT8D?
SPE2DR26FCT8D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FCT8D worth?
The government has obligated $16,696 on SPE2DR26FCT8D.
Is contract SPE2DR26FCT8D an order under another contract?
Yes. SPE2DR26FCT8D is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT8D competed?
The extent of competition for SPE2DR26FCT8D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award